NCT00493532 A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. Status NO_LONGER_AVAILABLE Phase N/A
NCT00493155 A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors. Status COMPLETED Phase PHASE1
NCT00488059 A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients Status TERMINATED Phase PHASE4
NCT00487747 A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B. Status COMPLETED Phase PHASE4
NCT00487188 A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience Status COMPLETED Phase PHASE4
NCT00486759 A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma Status TERMINATED Phase PHASE3
NCT00484939 A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00483938 The Individualized Management With Pegylated-interferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Offering Viral Eradication: A Study of Pegylated-interferon Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C (CHC) Non-genotype 2/3 (IMPROVE) Status COMPLETED Phase PHASE3
NCT00483834 A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00478270 A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease. Status WITHDRAWN Phase PHASE2
NCT00475670 A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00475423 A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura. Status COMPLETED Phase PHASE2
NCT00475072 A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C. Status COMPLETED Phase PHASE4
NCT00474955 A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure. Status COMPLETED Phase PHASE4
NCT00473083 Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer Status COMPLETED Phase PHASE2
NCT00472420 A Study of MabThera (Rituximab) Plus Standard Chemotherapy in Patients With Previously Untreated Mantle Cell Lymphoma. Status COMPLETED Phase PHASE2
NCT00472225 Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease Status UNKNOWN Phase PHASE2
NCT00468754 A Study Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections With Insulin Lispro and Glargine Status COMPLETED Phase NA
NCT00468702 Postoperative Canadian Oral Anticoagulation Self-management (Post-COAGS) Trial Status WITHDRAWN Phase NA